PEDITRACE CONCENTRATE FOR SOLUTION FOR INFUSION

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Achète-le

Ingrédients actifs:

ZINC CHLORIDE ; CUPRIC CHLORIDE DIHYDRATE ; MANGANESE CHLORIDE TETRAHYDRATE ; SODIUM SELENITE PENTAHYDRATE ; SODIUM FLUORIDE ; POTASSIUM IODIDE

Disponible depuis:

Fresenius Kabi Limited

Code ATC:

B05XA31

DCI (Dénomination commune internationale):

ZINC CHLORIDE ; CUPRIC CHLORIDE DIHYDRATE ; MANGANESE CHLORIDE TETRAHYDRATE ; SODIUM SELENITE PENTAHYDRATE ; SODIUM FLUORIDE ; POTASSIUM IODIDE

Dosage:

%v/v

forme pharmaceutique:

Solution for Infusion

Type d'ordonnance:

Product subject to prescription which may not be renewed (A)

Domaine thérapeutique:

electrolytes in combination with other drugs

Statut de autorisation:

Marketed

Date de l'autorisation:

1995-11-13

Notice patient

                                562
660
15816012H.indd 1
2016-06-03 14:50:57
15816012H.indd 2
2016-06-03 14:50:57
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Peditrace concentrate for solution for infusion.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Concentrate for solution for infusion
A sterile, clear, colourless solution for addition to certain infusion
fluids.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Peditrace is intended to meet the basal requirements for trace
elements during intravenous nutrition of infants and
children.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Paediatric population_
The basal requirements for infants and children of the included trace
elements are met by 1 ml of Peditrace per kg body
weight per day to a maximum daily dose of 15 ml.
A daily dose of 15 ml Peditrace should also meet the basic needs of
trace elements in children weighing 15-40 kg.
Above 40 kg the adult preparation Additrace should be used.
Method of administration
Peditrace should not be given undiluted.
Each 1 ml of Peditrace contains:
Zinc chloride
521
micrograms
Copper chloride 2H
2
O
53.7
micrograms
Manganese chloride 4H
2
O
3.60
micrograms
Sodium selenite anhydrous
4.38
micrograms
Sodium fluoride
126
micrograms
Potassium iodide
1.31
micrograms
The active ingredients in 1 ml correspond to:
Zinc
250
micrograms
3.82
micromol
Copper
20
micrograms
0.315
micromol
Manganese
1
micrograms
18.2
nmol
Selenium
2
micrograms
25.3
nmol
Flouride
57
micrograms
3.0
micromol
Iodine
1
micrograms
7.88
nmol
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_
                                
                                Lire le document complet